journal article·2008-12-23Open access

Detoxification of Gold Nanorods by Treatment with Polystyrenesulfonate

Alexei P. Leonov, Jiwen Zheng, Jeffrey D. Clogston, Stephan T. Stern, Anil K. Patri, Alexander Wei

ACS Nano· Volume 2· Issue 12

Abstract

We address an outstanding issue associated with the biocompatibility of gold nanorods (GNRs), a promising agent for biomedical imaging and theragnostics. GNRs are typically prepared in the presence of cetyltrimethylammonium bromide (CTAB), a cationic surfactant whose rigorous removal is necessary due to its cytotoxicity and membrane-compromising properties. CTAB-stabilized GNRs can be partially purified by treatment with polystyrenesulfonate (PSS), an anionic polyelectrolyte often used as a surrogate peptizing agent, followed by chloroform extraction and ultrafiltration with minimal loss of dispersion stability. However, in vitro cytotoxicity assays of PSS-coated GNRs revealed IC(50) values in the low to submicromolar range, with subsequent studies indicating the source of toxicity to be associated with a persistent PSS-CTAB complex. Further exchange of CTAB-laden PSS with fresh polyelectrolyte greatly improves biocompatibility, to the extent that 85 microg/mL of "CTAB-free" GNRs (the highest level evaluated) has comparable toxicity to a standard phosphate buffer solution. Ironically, PSS is not effective by itself at stabilizing GNRs in CTAB-depleted suspensions: while useful as a detergent for GNR detoxification, it should be replaced by more robust coatings for long-term stability under physiological conditions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery · Biosensors and Analytical Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Purdue University, West Lafayette, Indiana 47907

Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702

References (49)

Show source-provided references
1. Bentzen S. M. · Lancet Oncol. · 2005 · 6 · 11210.1016/S1470-2045(05)01737-7 ↗
2. Cuenca A. G. · Cancer · 2006 · 107 · 45910.1002/cncr.22035 ↗
3. Ozdemir V. · Nat. Biotechnol. · 2006 · 24 · 94210.1038/nbt0806-942 ↗
4. Huff T. B. · Nanomedicine · 2007 · 2 · 12510.2217/17435889.2.1.125 ↗
5. Tong L. · Adv. Mater. · 2007 · 19 · 313610.1002/adma.200701974 ↗
6. Huang X. · J. Am. Chem. Soc. · 2006 · 128 · 211510.1021/ja057254a ↗
7. Black K. C. · Mol. Imaging · 2008 · 7 · 5010.2310/7290.2008.0007 ↗
8. Pissuwan D. · J. Nanoparticle Res. · 2007 · 9 · 110910.1007/s11051-007-9212-z ↗
9. Pissuwan D. · Nano Lett. · 2007 · 7 · 380810.1021/nl072377+ ↗
10. Hirsch L. R. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 1354910.1073/pnas.2232479100 ↗
11. Gobin A. M. · Nano Lett. · 2007 · 7 · 192910.1021/nl070610y ↗
12. Chen J. · Nano Lett. · 2007 · 7 · 131810.1021/nl070345g ↗
13. Zharov V. P. · Biophys. J. · 2005 · 90 · 61910.1529/biophysj.105.061895 ↗
14. Zharov V. P. · Lasers Surg. Med. · 2005 · 37 · 21910.1002/lsm.20223 ↗
15. Cortesi R. · Int. J. Pharm. · 1996 · 139 · 6910.1016/0378-5173(96)04574-7 ↗
16. Mirska D. · Colloids Surf. B · 2005 · 40 · 5110.1016/j.colsurfb.2004.10.007 ↗
17. Takahashi H. · Langmuir · 2006 · 22 · 210.1021/la0520029 ↗
18. Connor E. E. · Small · 2005 · 1 · 32510.1002/smll.200400093 ↗
19. Huff T. B. · Langmuir · 2007 · 23 · 159610.1021/la062642r ↗
20. Hayat M. A. · 1989 · 1
21. Gole A. · Chem. Mater. · 2005 · 17 · 132510.1021/cm048297d ↗
22. Ding H. · J. Phys. Chem. C · 2007 · 111 · 1255210.1021/jp0733419 ↗
23. Kim K. · Appl. Phys. Lett. · 2007 · 90 · 22390110.1063/1.2743752 ↗
24. Durr N. J. · Nano Lett. · 2007 · 7 · 94110.1021/nl062962v ↗
25. Shepherd G. · J. Toxicol. Clin. Toxicol. · 2000 · 38 · 38910.1081/CLT-100100948 ↗
26. Nikoobakht B. · Chem. Mater. · 2003 · 15 · 195710.1021/cm020732l ↗
27. Sau T. K. · Langmuir · 2004 · 20 · 641410.1021/la049463z ↗
28. Zweifel D. A. · Chem. Mater. · 2005 · 17 · 425610.1021/cm0506858 ↗
29. Berr S. S. · J. Phys. Chem. · 1987 · 91 · 476010.1021/j100302a024 ↗
30. Introducing PSS prior to the first chloroform wash is less efficient and requires a greater amount of polyelectrolyte, due to the significant formation of soluble PSS−CTAB complex.
31. Chibowski S. · J. Colloid Interface Sci. · 1990 · 134 · 17410.1016/0021-9797(90)90264-O ↗
32. Hlady V. · J. Colloid Interface Sci. · 1982 · 87 · 39510.1016/0021-9797(82)90336-8 ↗
33. Ishigami A · Cell Tissue Res. · 2005 · 320 · 24310.1007/s00441-004-1073-5 ↗
34. Holmberg K. · 2003
35. Almgren M. · Langmuir · 1992 · 8 · 240510.1021/la00046a011 ↗
36. Maurdev G. · Langmuir · 2002 · 18 · 940110.1021/la0205349 ↗
37. Kogej K. · Langmuir · 1999 · 15 · 425110.1021/la9811517 ↗
38. Semchyschyn D. J. · Langmuir · 1996 · 12 · 25310.1021/la950244a ↗
39. Samokhina L. · Langmuir · 2007 · 23 · 361510.1021/la063178t ↗
40. Aslan K. · Langmuir · 2002 · 18 · 605910.1021/la025795x ↗
41. Dai Q. · Chem. Commun. · 2008 · 285810.1039/b804797a ↗
42. Liao H. · Chem. Mater. · 2005 · 17 · 463610.1021/cm050935k ↗
43. Niidome T. · J. Controlled Release · 2006 · 35 · 500
44. Zhao Y. · J. Am. Chem. Soc. · 2005 · 127 · 732810.1021/ja050432f ↗
45. Orendorff C. J. · J. Phys. Chem. B · 2006 · 110 · 399010.1021/jp0570972 ↗
46. Alley M. C. · Cancer Res. · 1988 · 48 · 589
47. Hansen M. B. · J. Immunol. Methods · 1989 · 119 · 20310.1016/0022-1759(89)90397-9 ↗
48. Decker T. · J. Immunol. Methods · 1988 · 15 · 6110.1016/0022-1759(88)90310-9 ↗
49. Korzeniewski C. · J. Immunol. Methods · 1983 · 64 · 31310.1016/0022-1759(83)90438-6 ↗